This inventor holds 1 USPTO granted patent. Top assignee: Pompeu Fabra University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Andres Ozaita Mintegui
Introduction
Andres Ozaita Mintegui is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of neuroscience through his innovative research and inventions. His work focuses on the treatment of diseases associated with neuronal dendritic abnormalities.
Latest Patents
Andres holds a patent for "Antagonists of the cannabinoid receptor CB1 for use in the treatment of diseases associated with neuronal dendritic abnormalities." This invention relates to the use of antagonists of the cannabinoid receptor CB1 in the treatment and prevention of various diseases, including Down's syndrome, Angelman's syndrome, Rett syndrome, and tuberous sclerosis. Specifically, the invention provides a method of treatment or prevention of such diseases by administering the compound rimonabant. He has 1 patent to his name.
Career Highlights
Andres is affiliated with Universitat Pompeu Fabra, where he conducts his research and development. His work has garnered attention for its potential impact on treating complex neurological conditions.
Collaborations
Andres collaborates with fellow researcher Arnau Busquets Garcia, contributing to advancements in their shared field of study.
Conclusion
Andres Ozaita Mintegui's innovative work in the realm of cannabinoid receptor antagonists showcases his commitment to addressing significant health challenges. His contributions are paving the way for new treatment options for various neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile